ClinicalTrials.gov
ClinicalTrials.gov Menu

Effects of Tolterodine, a Non-Specific Muscarinic Antagonist, on Gastrointestinal Transit in Healthy Subjects

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00332137
Recruitment Status : Completed
First Posted : June 1, 2006
Last Update Posted : March 23, 2011
Sponsor:
Collaborator:
Pfizer
Information provided by:
Mayo Clinic

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : August 2007
  Actual Study Completion Date : August 2007